STAT3 and neurodegenerative disease: Additionally, CREB activation and the upregulation of its target genes, essential for synaptic plasticity and LTM, suggest that STAT3 inhibition may offer a promising therapeutic strategy for addressing memory deficits in neurodegenerative diseases.